Spain
Manina Medtech is a Spain-based startup founded in 2021 with the ambitious goal of revolutionizing In Vitro Fertilisation (IVF) success rates. With a slogan of "Boosting In Vitro Fertilisation Success," the company aims to address the significant global health issue of infertility, affecting an estimated 190 million people worldwide. Despite a growing awareness of IVF as a potential solution, the low success rate of about 40% out of nearly a million IVF cycles in Europe annually has made the process arduous, financially burdensome, and emotionally distressing for individuals and couples.
Manina Medtech is strategically positioned as a B2B entity, with the vision of transforming the IVF landscape so that every woman undergoing the process achieves pregnancy within a single IVF cycle. The recent Pre Seed Round investment of €1.75M secured on 03 January 2024 from Medex Partners and the Ministry of Science and Innovation of Spain underscores the financial backing and confidence in the company's vision. This significant investment signifies a vote of confidence in Manina Medtech's potential to disrupt and improve the IVF industry significantly.
By addressing the core challenges in IVF, Manina Medtech aims to make the entire process of infertility treatment faster, healthier, and more affordable, offering a promising solution to a longstanding global health problem. The company's ambitious vision and recent investment underscore its potential to make a meaningful impact in the field of reproductive health and technology.
